跳至主要内容
临床试验/NCT03359304
NCT03359304尚未招募不适用

Establishment of Neurofibromatosis-associated Tumours Biobank for Future Genomic-based Research Aiming at Improved Outcome Prediction

Ren tingting0 个研究点目标入组 300 人开始时间: 2018年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
300
主要终点
Detected NF-1 gene expression pattern in neurofibromatosis-asociated tumor

研究概览

简要总结

Neurofibromatosis-associated Tumor is very rare bone tumor. The investigator set up the biobank to ensure every patient has the chance to participate in future research

详细描述

Samples of blood and other stored material such as slides,frozen tissues or leftover diagnostic material.

Questionnaire information, including health history, growth and development, physical activity and family medical history information.

If patients have been diagnosed with a neurofibromatosis-associated tumor or another condition the investigator is interested in, the investigator will ask the patient to release medical record information relating to diagnosis and treatment of neurofibromatosis-associated tumor, other cancers, blood disorders, and similar conditions.

研究设计

研究类型
Observational
观察模型
Family Based
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Proband Inclusion criteria: A diagnosis or suspected diagnosis of neurofibromatosis-associated tumor Family member inclusion criteria: Biological parents and full biological siblings of a case diagnosed with neurofibromatosis-associated tumor

排除标准

  • 未提供

结局指标

主要结局

Detected NF-1 gene expression pattern in neurofibromatosis-asociated tumor

时间窗: 3 years

To examine the neurofibromatosis type 1(NF-1) gene expression of the patients with neurofibromatosis-associated tumor

次要结局

未报告次要终点

研究者

发起方
Ren tingting
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Ren tingting

Musculoskeletal Tumor Center

Peking University People's Hospital

相似试验